● Colossal Biosciences, a biotechnology startup that promises to resurrect woolly mammoths, is now t

● Colossal Biosciences, a biotechnology startup that promises to resurrect woolly mammoths, is now the first “de-extinction unicorn,” with a valuation said to be over a $1 billion before bringing back a single lost species.● Reintroducing mammoths to Alaska or dodos to Mauritius sounds unrealistic, even silly, and has drawn skepticism from paleo-geneticists and other experts who worry that the effects of de-extinction would be unpredictable. Yet Colossal has continued to draw support from investors, including celebrities.● Company insiders regularly bring up the space race when discussing the company's prospects as an example of a seemingly-impossible goal that was not only eventually reached but also generated collateral inventions that we still use today.● Tap the link in our bio for more. (📸: Colossal Biosciences)
#entrepreneurship #bestentrepreneurship #undefined